Sarcoma Metastatic

Explore clinical trials studying Sarcoma Metastatic. Study availability and eligibility vary by location and protocol.

7 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Sarcoma Metastatic trial results

Recruiting

Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma

NCT07291297

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +3 more
Locations: Levine Cancer Institute Charlotte, North Carolina, United States

Atrium Health Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Recruiting

XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma

NCT06571734

Conditions: Bone Diseases, Bone Neoplasms, Bone Sarcoma, +22 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details

Recruiting

Superiority Trial Evaluating Digitalized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatment.

NCT06211257

Conditions: Brain Diseases, Central Nervous System Diseases, Locally Advanced Soft Tissue Sarcoma, +7 more
Locations: Centre Léon Bérard Lyon, Auvergne-Rhône-Alpes, France

CHU Jean Minjoz Besançon, Bourgogne-Franche-Comté, France

Centre Eugène Marquis Rennes, Brittany Region, France

Centre Paul Strauss Strasbourg, Grand Est, France

View Trial Details

Recruiting

Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas

NCT07066982

Conditions: DNA Virus Infections, Hemic and Lymphatic Diseases, Herpesviridae Infections, +23 more
Locations: District One Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Pilot Study of TumorGlow for Intraoperative Molecular Imaging of Sarcoma Metastases to the Lungs in Pediatric Patients

NCT07658768

Conditions: Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Benefits of Early Collaboration Between Oncologists and Palliative Care Physicians in Cases of Unplanned Hospitalization for Patients With Metastatic Cancer

NCT07490106

Conditions: Cancer, Digestive Cancers, Digestive System Diseases, +13 more
Locations: Centre Oscar Lambret Lille, France

View Trial Details

Completed

Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma

NCT04076579

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations: University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Sarcoma Metastatic

Sarcoma Metastatic trial results

Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma

XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma

Superiority Trial Evaluating Digitalized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatment.

Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas

Pilot Study of TumorGlow for Intraoperative Molecular Imaging of Sarcoma Metastases to the Lungs in Pediatric Patients

Benefits of Early Collaboration Between Oncologists and Palliative Care Physicians in Cases of Unplanned Hospitalization for Patients With Metastatic Cancer

Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma

Related conditions